Simulation analysis of coronary heart disease, congestive heart failure and end-stage renal disease economic burden

2011 ◽  
Vol 82 (3) ◽  
pp. 494-507 ◽  
Author(s):  
M. Atanasijević-Kunc ◽  
J. Drinovec ◽  
S. Ručigaj ◽  
A. Mrhar
Keyword(s):  
Heart Failure ◽  
Coronary Heart Disease ◽  
Congestive Heart Failure ◽  
Heart Disease ◽  
Renal Disease ◽  
Economic Burden ◽  
End Stage Renal Disease ◽  
Simulation Analysis ◽  
Stage Renal Disease ◽  
End Stage

scholarly journals Survival advantage of hemodialysis relative to peritoneal dialysis in patients with end-stage renal disease and congestive heart failure

2011 ◽  
Vol 80 (9) ◽  
pp. 970-977 ◽  
Author(s):  
Florence Sens ◽  
Anne-Marie Schott-Pethelaz ◽  
Michel Labeeuw ◽  
Cyrille Colin ◽  
Emmanuel Villar
Keyword(s):  
Heart Failure ◽  
Congestive Heart Failure ◽  
Peritoneal Dialysis ◽  
Renal Disease ◽  
End Stage Renal Disease ◽  
Survival Advantage ◽  
Stage Renal Disease ◽  
End Stage

Risk of heart failure in type 2 diabetes complicated by incident ischaemic heart disease and end‐stage renal disease

2020 ◽  
Vol 22 (5) ◽  
pp. 813-820 ◽  
Author(s):  
Mariam E. Malik ◽  
Christian Madelaire ◽  
Maria D'Souza ◽  
Paul Blanche ◽  
Søren L. Kristensen ◽  
...  
Keyword(s):  
Heart Failure ◽  
Type 2 Diabetes ◽  
Heart Disease ◽  
Renal Disease ◽  
Ischaemic Heart Disease ◽  
End Stage Renal Disease ◽  
Stage Renal Disease ◽  
End Stage

Coronary artery calcium distribution and interscan measurement variability in end-stage renal and coronary heart disease patients

2009 ◽  
Vol 50 (3) ◽  
pp. 288-295 ◽  
Author(s):  
Z. Serafin ◽  
K. Laskowska ◽  
M. Marzec ◽  
T. A. Sinjab ◽  
W. Lasek ◽  
...  
Keyword(s):  
Coronary Heart Disease ◽  
Heart Disease ◽  
Coronary Artery ◽  
Renal Disease ◽  
End Stage Renal Disease ◽  
Coronary Calcium ◽  
Calcium Distribution ◽  
Stage Renal Disease ◽  
End Stage ◽  
Single Lesion

Background: Coronary heart disease patients and end-stage renal disease patients have been documented to have an increased amount of coronary artery calcifications (CAC). Purpose: To evaluate the distribution of CAC and its influence on interscan variability of measurement in end-stage renal disease and coronary heart disease patients, proven to have calcifications. Material and Methods: 69 patients having CAC, including 34 with coronary heart disease and 35 with end-stage renal disease, were scanned twice with multidetector-row computed tomography (MDCT). Amount of CAC was determined as the number of calcified lesions (CN), total calcium score (CS), calcium volume (CV), and calcium mass (CM). Distribution of CAC was evaluated on a per-patient basis as the median CS and CM of a single lesion. Density of the calcifications was calculated as the patient's CM divided by CV. Results: The overall median CS was 457.2, and the median CM was 75.6 mg. There were no significant differences in the number of calcified lesions, CS, or CM between the two groups. Both CS and CM of a single lesion, as well as the mean calcium density were lower in renal disease patients ( P<0.05) than in coronary heart disease subjects. The relative interscan variability of coronary calcium measurement was higher in the renal disease group ( P<0.05). There was a negative correlation between the calcium concentration and the relative interscan variability. Conclusion: The results indicate that the coronary calcium distribution influences the measurement interscan reproducibility, and the distribution may differ between end-stage renal disease patients and coronary heart disease patients, reflecting the dissimilar nature of coronary calcifications in those groups.

Sign in / Sign up

Export Citation Format

Share Document